Back to LYEL
CHARLES SCHWAB INVESTMENT MANAGEMENT INC → LYEL
CHARLES SCHWAB INVESTMENT MANAGEMENT INC LYEL Position History
Lyell Immunopharma, Inc. • Healthcare
Quarters held
4
Latest value
$912K
Q3 2026
Peak value
$2.6M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $2.6M |
| Q1 2026 | $1.7M |
| Q2 2026 | $1.5M |
| Q3 2026 | $912K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $912K | 93.1K | — | — |
| Q2 2026 | $1.5M | 107.6K | — | — |
| Q1 2026 | $1.7M | 86.0K | — | — |
| Q4 2025 | $2.6M | 85.4K | — | — |
Other funds holding LYEL
$46.6M
$30.3M
$23.2M